Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

SHA:603456 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,811	2,749	3,206	1,095	1,121	324.57
Trading Asset Securities	-	-	-	-	26.06	27.45
Cash & Short-Term Investments	2,811	2,749	3,206	1,095	1,147	352.03
Cash Growth	-5.00%	-14.27%	192.71%	-4.49%	225.79%	-37.71%
Accounts Receivable	1,261	1,255	997.69	767.03	850.02	691.24
Other Receivables	14.57	11.8	8.32	6.46	5.72	8.52
Receivables	1,275	1,266	1,006	773.49	855.74	699.77
Inventory	1,606	1,929	1,959	2,021	1,682	1,170
Other Current Assets	121.78	127.5	142.55	102.87	87.38	73.69
Total Current Assets	5,815	6,071	6,314	3,993	3,772	2,295
Property, Plant & Equipment	4,270	4,274	3,722	3,144	2,645	2,321
Long-Term Investments	203.47	108.08	121.88	109.13	101.07	29.87
Goodwill	88.12	88.6	110.11	111.11	70.35	75.07
Other Intangible Assets	503.56	516.11	504.74	454.03	412.47	235.78
Long-Term Deferred Tax Assets	1.36	1.68	0.75	24.43	11.21	7.58
Long-Term Deferred Charges	74.07	64.76	73.2	69.07	16.21	0.14
Other Long-Term Assets	0.3	2.9	4.74	8.38	12.15	36.54
Total Assets	10,955	11,127	10,852	7,914	7,040	5,002
Accounts Payable	1,171	1,459	1,198	1,245	988.14	530.25
Accrued Expenses	172.53	202.63	227.81	201.85	168.05	149.82
Short-Term Debt	301.14	-	-	50.05	498.84	788.02
Current Portion of Long-Term Debt	100.08	201.93	7.77	200.21	-	10.01
Current Portion of Leases	6.14	7.79	6.78	6.59	1.01	-
Current Income Taxes Payable	37.96	55.74	55.3	78.8	75.37	26.86
Current Unearned Revenue	70.23	69.75	75.41	83.08	49.64	22.76
Other Current Liabilities	46.39	49.84	85.95	348.37	303.65	105.32
Total Current Liabilities	1,905	2,046	1,657	2,214	2,085	1,633
Long-Term Debt	-	194.25	389.05	83.99	201.49	140.19
Long-Term Leases	8.41	8.03	11.89	10.6	3.25	-
Long-Term Unearned Revenue	146.28	139.89	109.12	101.2	97.31	92.49
Long-Term Deferred Tax Liabilities	89.58	87.47	101.47	106.26	76.55	49.95
Other Long-Term Liabilities	26.57	41.76	50.77	25.76	-	-
Total Liabilities	2,176	2,518	2,319	2,542	2,463	1,916
Common Stock	889.45	895.24	899.49	834.25	832.6	805.23
Additional Paid-In Capital	4,285	4,380	4,499	2,058	1,985	971.34
Retained Earnings	3,612	3,350	3,190	2,515	1,802	1,335
Treasury Stock	-102	-99.9	-132.01	-113.12	-44.43	-30.66
Comprehensive Income & Other	26	11.52	4.65	2.26	1.49	2.54
Total Common Equity	8,710	8,537	8,461	5,297	4,577	3,083
Minority Interest	68.79	72.91	71.94	75.1	-	2.91
Shareholders' Equity	8,779	8,610	8,533	5,372	4,577	3,086
Total Liabilities & Equity	10,955	11,127	10,852	7,914	7,040	5,002
Total Debt	415.76	412	415.49	351.44	704.58	938.22
Net Cash (Debt)	2,396	2,337	2,791	743.98	442.29	-586.2
Net Cash Growth	-4.60%	-16.27%	275.13%	68.21%	-	-
Net Cash Per Share	2.70	2.62	3.13	0.90	0.53	-0.72
Filing Date Shares Outstanding	881.71	889.45	899.49	834.25	832.6	831.41
Total Common Shares Outstanding	881.71	889.45	899.49	834.25	832.6	805.23
Working Capital	3,910	4,025	4,658	1,779	1,687	662.34
Book Value Per Share	9.88	9.60	9.41	6.35	5.50	3.83
Tangible Book Value	8,119	7,932	7,846	4,732	4,094	2,772
Tangible Book Value Per Share	9.21	8.92	8.72	5.67	4.92	3.44
Buildings	1,971	1,966	1,786	1,612	1,562	1,354
Machinery	4,699	4,665	4,350	4,010	3,684	3,326
Construction In Progress	1,669	1,566	1,198	839.25	471.51	300.08

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.